Genetic Testing
Middle East · 3 shared keywords
Updated
Reviewed by Vidhi Upadhyay
Middle East Molecular Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Technology, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.94 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.08 Bn | — | — |
| 2025 (base) | $1.20 Bn | +$121.8 Mn | — |
| 2026 (forecast) | $1.33 Bn | +$135.5 Mn | +11.3% |
| 2027 (forecast) | $1.49 Bn | +$150.8 Mn | +23.9% |
| 2028 (forecast) | $1.65 Bn | +$167.9 Mn | +37.9% |
| 2029 (forecast) | $1.84 Bn | +$186.9 Mn | +53.5% |
| 2030 (forecast) | $2.05 Bn | +$208.0 Mn | +70.8% |
| 2031 (forecast) | $2.28 Bn | +$231.5 Mn | +90.1% |
| 2032 (forecast) | $2.54 Bn | +$257.6 Mn | +111.6% |
| 2033 (forecast) | $2.82 Bn | +$286.7 Mn | +135.5% |
| 2034 (forecast) | $3.14 Bn | +$319.2 Mn | +162.1% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.20 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $3.14 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 11.3% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Technology, application and end user (see all) |
| Key players | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Hologic, Inc. and 1 more (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Molecular diagnostics tests read DNA, RNA and proteins to find infections, cancer and inherited disease.
Key segments of the molecular diagnostics market include technology (PCR, Sequencing and Isothermal Amplification) and application (Infectious Disease, Oncology and Genetic Disease).
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the molecular diagnostics market.
Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the molecular diagnostics market room to grow.
Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the molecular diagnostics market.
The molecular diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medical devices are regulated by SFDA (Saudi Arabia)[1], EDE (UAE)[2], Ministry of Public Health (Qatar)[3] and AMAR (Israel)[4]. How care is paid for in some of these countries: free public care and CHI-regulated insurance (Saudi Arabia)[5], mandatory health insurance (UAE)[6], public care and compulsory insurance (Qatar)[3] and four health funds (Israel)[4].
[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.
[2] Emirates Drug Establishment. Checked 14 Nov 2026.
[3] Ministry of Public Health, Qatar. Checked 19 Nov 2026.
[4] Israel Ministry of Health. Checked 19 Nov 2026.
[5] Council of Health Insurance. Checked 14 Nov 2026.
[6] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how molecular diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Middle East.
From our blog
Middle East · 3 shared keywords
Middle East · 3 shared keywords
Middle East · 2 shared keywords
Middle East · 2 shared keywords
Middle East · 2 shared keywords
Middle East · 1 shared keyword
Pharmaceuticals · Middle East
Digital Health · Middle East
Healthcare Services · Middle East
Healthcare Services · Middle East
Digital Health · Middle East
Healthcare Services · Middle East